Silicosis medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Template) |
||
| (13 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Silicosis}} | {{Silicosis}} | ||
{{CMG}} | {{CMG}} {{AE}} {{AV}} | ||
==Overview== | ==Overview== | ||
Silicosis is an irreversible condition with currently no cure. | Silicosis is an irreversible condition with currently no cure. Treatment options currently focus on alleviating the symptoms and preventing complications. | ||
==Medical Therapy== | ==Medical Therapy== | ||
* | * There is no evidence-based medical therapy for the treatment of silicosis. | ||
*Generally, management of silicosis aims to manage other respiratory comorbidities (e.g. [[COPD]] or [[tuberculosis]]) and to treat silicosis-associated complications. | |||
* Management goals include avoidance of exposure to silica, optimization of respiratory function, and preventive care. | |||
===Management of Acute Silicosis=== | |||
*A modest short-term randomized clinical trial demonstrated that [[systemic steroids]] may be effective in the management of [[steroids]], but the benefit has not been well-established<ref name="pmid1735256">{{cite journal| author=Goodman GB, Kaplan PD, Stachura I, Castranova V, Pailes WH, Lapp NL| title=Acute silicosis responding to corticosteroid therapy. | journal=Chest | year= 1992 | volume= 101 | issue= 2 | pages= 366-70 | pmid=1735256 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1735256 }} </ref> | |||
*[[Lung lavage|Whole-lung lavage]] is recommended in acute silicosis to improve gas exchange and eliminate residual alveolar debris, although not routinely recommended because of the ill effects<ref name="pmid23632425">{{cite journal| author=Stafford M, Cappa A, Weyant M, Lara A, Ellis J, Weitzel NS et al.| title=Treatment of acute silicoproteinosis by whole-lung lavage. | journal=Semin Cardiothorac Vasc Anesth | year= 2013 | volume= 17 | issue= 2 | pages= 152-9 | pmid=23632425 | doi=10.1177/1089253213486524 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23632425 }} </ref> | |||
===Management of Chronic Silicosis=== | |||
*Systemic [[steroid]] therapy are not recommended for the indication of chronic silicosis alone. However, systemic [[steroids]] may be administered to patients who are diagnosed with silicosis and have other indications like [[COPD]] flare up for the use of [[steroids]]<ref name="pmid2008993">{{cite journal| author=Sharma SK, Pande JN, Verma K| title=Effect of prednisolone treatment in chronic silicosis. | journal=Am Rev Respir Dis | year= 1991 | volume= 143 | issue= 4 Pt 1 | pages= 814-21 | pmid=2008993 | doi=10.1164/ajrccm/143.4_Pt_1.814 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2008993 }} </ref> | |||
===Supportive therapy=== | ===Supportive therapy=== | ||
*Smoking cessation | *[[Smoking cessation]] | ||
* [[ | *[[oxygen|Supplemental oxygen]] is administered to prevent complications of chronic [[hypoxemia]] | ||
*[[Bronchodilator]]s may facilitate breathing if airflow limitation is present on [[spirometry]]. | |||
* [[ | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 15:38, 8 June 2016
|
Silicosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Silicosis medical therapy On the Web |
|
American Roentgen Ray Society Images of Silicosis medical therapy |
|
Risk calculators and risk factors for Silicosis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Overview
Silicosis is an irreversible condition with currently no cure. Treatment options currently focus on alleviating the symptoms and preventing complications.
Medical Therapy
- There is no evidence-based medical therapy for the treatment of silicosis.
- Generally, management of silicosis aims to manage other respiratory comorbidities (e.g. COPD or tuberculosis) and to treat silicosis-associated complications.
- Management goals include avoidance of exposure to silica, optimization of respiratory function, and preventive care.
Management of Acute Silicosis
- A modest short-term randomized clinical trial demonstrated that systemic steroids may be effective in the management of steroids, but the benefit has not been well-established[1]
- Whole-lung lavage is recommended in acute silicosis to improve gas exchange and eliminate residual alveolar debris, although not routinely recommended because of the ill effects[2]
Management of Chronic Silicosis
- Systemic steroid therapy are not recommended for the indication of chronic silicosis alone. However, systemic steroids may be administered to patients who are diagnosed with silicosis and have other indications like COPD flare up for the use of steroids[3]
Supportive therapy
- Smoking cessation
- Supplemental oxygen is administered to prevent complications of chronic hypoxemia
- Bronchodilators may facilitate breathing if airflow limitation is present on spirometry.
References
- ↑ Goodman GB, Kaplan PD, Stachura I, Castranova V, Pailes WH, Lapp NL (1992). "Acute silicosis responding to corticosteroid therapy". Chest. 101 (2): 366–70. PMID 1735256.
- ↑ Stafford M, Cappa A, Weyant M, Lara A, Ellis J, Weitzel NS; et al. (2013). "Treatment of acute silicoproteinosis by whole-lung lavage". Semin Cardiothorac Vasc Anesth. 17 (2): 152–9. doi:10.1177/1089253213486524. PMID 23632425.
- ↑ Sharma SK, Pande JN, Verma K (1991). "Effect of prednisolone treatment in chronic silicosis". Am Rev Respir Dis. 143 (4 Pt 1): 814–21. doi:10.1164/ajrccm/143.4_Pt_1.814. PMID 2008993.